Novo Nordisk A/S Common Stock · Operating Cash Flow (Statement)

Latest reportedkr 133.01B DKKperiod endingJun 30, 2026

NVO Cash from Operations · DKK (kr 1.50B → kr 133.01B)

Annual operating cash flow (statement)

High-resolution chart · PNG

NVO operating cash flow (statement) history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (DKK)
Period ending	Operating Cash Flow (Statement) (DKK)
Dec 31, 2025	119,102,000,000
Dec 31, 2024	120,968,000,000
Dec 31, 2023	108,908,000,000
Dec 31, 2022	78,887,000,000
Dec 31, 2021	55,000,000,000
Dec 31, 2020	51,951,000,000
Dec 31, 2019	46,782,000,000
Dec 31, 2018	44,616,000,000
Dec 31, 2017	41,168,000,000
Dec 31, 2016	48,314,000,000
Dec 31, 2015	38,287,000,000
Dec 31, 2014	31,692,000,000
Dec 31, 2013	25,942,000,000
Dec 31, 2012	22,214,000,000
Dec 31, 2011	21,374,000,000
Dec 31, 2010	19,679,000,000
Dec 31, 2009	15,378,000,000
Dec 31, 2008	12,896,921,200
Dec 31, 2007	9,997,870,000
Dec 31, 2006	7,741,322,000
Dec 31, 2005	8,699,492,400
Dec 31, 2004	7,644,519,330
Dec 31, 2003	6,178,771,500
Dec 31, 2002	4,876,528,410
Dec 31, 2001	4,310,669,160
Dec 31, 2000	5,261,907,200
Dec 31, 1999	3,629,967,910
Dec 31, 1998	3,475,574,214
Dec 31, 1997	3,031,860,456
Dec 31, 1996	1,921,666,906
Dec 31, 1995	2,529,923,000
Dec 31, 1994	2,662,826,110
Dec 31, 1993	1,912,113,000
Dec 31, 1992	1,327,888,250
Dec 31, 1991	1,186,248,100
Dec 31, 1990	1,504,070,400